SARS News and Research

RSS

Exploring factors favoring transmission of SARS-CoV-2 Delta sublineage AY.4.2 over the Delta variant

In the present study, researchers isolated an infectious AY.4.2 strain of COVID-19 from the nasopharyngeal swab of a symptomatic individual from the Paris region. Then, they introduced the AY.4.2 signature mutations - T95I, Y145H, and A222V - in an expression plasmid coding the Delta protein to study the function of the AY.4.2 S protein.

13 Jan 2022

Forecasting seasonal SARS-CoV-2 mutations

In a study published in Science Translational Medicine, researchers have been trying to create a technique to predict which of these mutations will spread.

13 Jan 2022

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

In a new study, researchers assessed the sera from COVID-19 infected and vaccinated individuals against the receptor-binding domain in the spike protein of the SARS-CoV-2 wildtype virus and its variants.

13 Jan 2022

Study finds reductions in hospital admissions for childhood infections during first year of pandemic

During the first year or so of the covid-19 pandemic, there were dramatic reductions in hospital admissions for common and severe childhood infections in England, most likely due to social distancing measures, school and workplace closures, and travel restrictions, finds a study published by The BMJ today.

13 Jan 2022

Nanovaccines and their immunomodulatory effect against human viruses

A review ]presented the primary progress of nanovaccines against the main viral illnesses.

13 Jan 2022

The unique T cell response elicited by SARS-CoV-2 during a primary immune response by infection and vaccination

The distinctive characteristics of the T cell response generated by SARS-CoV-2 infection and vaccination and the relationship to CCCoVs and VOC was explored in a review published in Frontiers in Medicine.

13 Jan 2022

Using lab-grown stomachs to shed light on the symptoms of COVID-19

Could lab-grown 'mini-stomachs' be used to look at COVID-19 symptoms in children? In this interview, we speak to Paolo De Coppi to find out more.

13 Jan 2022

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have the potential to prevent and treat the infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – primarily by blocking viral cell entry.

13 Jan 2022

A clinical tool for monoclonal antibody allocation to treat COVID-19

In this research paper, a group of Mayo Clinic researchers discusses how data from MATRx's clinical prioritizing algorithms can be used to address anti-spike monoclonal antibody allocation during times of scarcity.

13 Jan 2022

The zoonotic potential of epidemic porcine deltacoronavirus

The present state of knowledge about the genesis, evolution, cross-species transmission, and zoonotic potential of PDCoV is the subject of a review published in the journal Pathogens, which was conducted in a combined effort by researchers from Heilongjiang Bayi Agricultural University and Ohio State University.

13 Jan 2022

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Recently, the researchers from the USA, in their study published in the journal EBioMedicine, have conducted a sequence identity comparison and 3D protein structure comparison between the SARS-CoV-2 spike protein-derived peptides/protein and myocarditis-associated antigens and have found no significant enrichment in the frequency of spike-derived peptides similar to myocarditis-associated antigens that could have resulted in adaptive autoimmune responses leading to myocarditis.

12 Jan 2022

How did the COVID pandemic affect the spread of other zoonotic diseases?

In new research, scientists from the Beijing University of Technology have been investigating the impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China. Their work is published in the journal BMJ Global Health.

12 Jan 2022

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

Researchers examine the effects of disease-modifying therapies implemented for treating multiple sclerosis on the immune response to SARS-CoV-2 infection.

12 Jan 2022

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

Researchers observe an increase in PEG antibodies following vaccination with the SARS-CoV-2 mRNA lipid nanoparticle vaccine.

12 Jan 2022

How much protection does SARS-CoV-2 infection provide against reinfection?

Researchers determine whether previous SARS-CoV-2 infection protects from reinfection.

12 Jan 2022

High SARS-CoV-2 seroprevalence among captive white-tailed deer in Texas

Researchers investigate the SARS-CoV-2 exposure and infection status of captive white-tailed deer in Texas.

12 Jan 2022

Estimating transmission advantage of SARS-CoV-2 Omicron over Delta in the UK

Researchers estimate daily growth rates for the SARS-CoV-2 Omicron and Delta variants in each UKHSA region of England.

12 Jan 2022

Dynamics of hospital-acquired SARS-CoV-2 infection in a geriatric setting

Researchers investigated the extent of nosocomial SARS-CoV-2 infection among elderly patients and healthcare workers in a geriatric hospital.

12 Jan 2022

Greater psychological distress linked with higher SARS-CoV-2 infection risk

A new study has found that people who experienced increased stress, anxiety and depression at the start of the pandemic, were at greater risk of getting Covid-19.

12 Jan 2022

Study: Face masks reduce the distance airborne pathogens could travel by more than half

The effectiveness of face masks has been a hotly debated topic since the emergence of COVID-19. However, a new study by researchers at the University of Central Florida offers more evidence that they work.

12 Jan 2022

SARS News and Research

Exploring factors favoring transmission of SARS-CoV-2 Delta sublineage AY.4.2 over the Delta variant

Forecasting seasonal SARS-CoV-2 mutations

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

Study finds reductions in hospital admissions for childhood infections during first year of pandemic

Nanovaccines and their immunomodulatory effect against human viruses

The unique T cell response elicited by SARS-CoV-2 during a primary immune response by infection and vaccination

Using lab-grown stomachs to shed light on the symptoms of COVID-19

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A clinical tool for monoclonal antibody allocation to treat COVID-19

The zoonotic potential of epidemic porcine deltacoronavirus

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

How did the COVID pandemic affect the spread of other zoonotic diseases?

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

How much protection does SARS-CoV-2 infection provide against reinfection?

High SARS-CoV-2 seroprevalence among captive white-tailed deer in Texas

Estimating transmission advantage of SARS-CoV-2 Omicron over Delta in the UK

Dynamics of hospital-acquired SARS-CoV-2 infection in a geriatric setting

Greater psychological distress linked with higher SARS-CoV-2 infection risk

Study: Face masks reduce the distance airborne pathogens could travel by more than half

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News